Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Insights and Therapeutic Challenges in the Management of Giant Complex Vascular Malformation of the Buttock.

Journal of Indian Association of Pediatric Surgeons·2026
Same author

Modulation of the Unfolded Protein Response by Viruses: Mechanistic Insights and Implications for viral Pathogenesis.

Current protein & peptide science·2026
Same author

Virus-like particles: Bridging immunization and precision drug delivery.

Gene·2026
Same author

Design and Evaluation of Semi-Synthetic Morin Derivatives as Promising Antitumor Agents against Breast and Liver Cancer.

Current drug discovery technologies·2026
Same author

Herbal remedies for hepatic diseases: A review of medicinal herbs in the treatment of liver disorders.

Chinese herbal medicines·2026
Same author

A comprehensive review on artificial intelligence driven approaches for vaccine development: Current advances, challenges, and future prospects.

Current research in translational medicine·2026
Same journal

Discovery of Phytochemicals as Inhibitors of Human Metapneumovirus: In-Silico Docking Studies.

Current drug discovery technologies·2026
Same journal

From Molecules to Manufacturing: Expanding Role of Artificial Intelligence in Pharmaceutical Sciences.

Current drug discovery technologies·2026
Same journal

Targeting Biofilm Formation in Acinetobacter baumannii: In Silico Discovery of Novel Candidate Inhibitors for Acyl-Homoserine Lactone Synthase.

Current drug discovery technologies·2026
Same journal

Effects of Ganoderma lucidum Polysaccharide Peptide on Inflammatory and Metabolic Biomarkers in Obese Patients with Cardiometabolic Syndrome: A Randomized Controlled Trial.

Current drug discovery technologies·2026
Same journal

Using Computational Intelligence to Connect Data and Drug Design in Medicinal Chemistry: A Review.

Current drug discovery technologies·2026
Same journal

Uncovering the Anti-Pleurisy Mechanism of Shizao Decoction via Network Pharmacology and Molecular Docking.

Current drug discovery technologies·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

8.2K

Vaccine Designing Technology against Leishmaniasis: Current Challenges and Implication.

Jyoti Gupta1, Yukta Menon1, Subodh Kumar2

  • 1Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector-62, Noida, 201309, India.

Current Drug Discovery Technologies
|May 27, 2024
PubMed
Summary
This summary is machine-generated.

Developing a Leishmaniasis vaccine faces challenges due to complex parasite-host interactions. Innovative methods like immunoinformatics and Omics data offer promising strategies for effective vaccine design against this sandfly-transmitted disease.

Keywords:
Leishmaniasisamastigotebioinformatics tools.computer-aided designpromastigotereverse vaccinologyvaccine designing

More Related Videos

Development of Leishmania Species Strains with Constitutive Expression of eGFP
10:03

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

778
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

394

Related Experiment Videos

Last Updated: May 3, 2026

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
06:57

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

8.2K
Development of Leishmania Species Strains with Constitutive Expression of eGFP
10:03

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

778
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

394

Area of Science:

  • Parasitology
  • Immunology
  • Vaccinology

Background:

  • Leishmaniasis, a sandfly-borne protozoan disease, poses significant global health challenges.
  • Vaccine development is hindered by complex parasite life cycle stages and host immune responses.

Purpose of the Study:

  • To explore innovative strategies for developing a potent Leishmaniasis vaccine.
  • To address obstacles impeding vaccine efficacy and design.

Main Methods:

  • Utilizing reverse vaccinology and computer-aided design for identifying vaccine candidates.
  • Leveraging Omics data and immunoinformatics approaches for enhanced vaccine design.

Main Results:

  • Innovative computational and data-driven methods show promise in overcoming design complexities.
  • Understanding host-pathogen interactions is crucial for identifying effective vaccine targets.

Conclusions:

  • Despite challenges like co-infections and treatment limitations, persistent research offers hope for an effective Leishmaniasis vaccine.
  • The integration of Omics data and immunoinformatics is key to advancing vaccine development for Leishmaniasis prevention.